Barton D J, Flanegan J B
Department of Immunology and Medical Microbiology, University of Florida College of Medicine, Gainesville 32610-0266.
J Virol. 1993 Feb;67(2):822-31. doi: 10.1128/JVI.67.2.822-831.1993.
Poliovirus RNA polymerase and infectious virus particles were synthesized by translation of virion RNA in vitro in HeLa S10 extracts. The in vitro translation reactions were optimized for the synthesis of the viral proteins found in infected cells and in particular the synthesis of the viral polymerase 3Dpol. There was a linear increase in the amount of labeled protein synthesized during the first 6 h of the reaction. The appearance of 3Dpol in the translation products was delayed because of the additional time required for the proteolytic processing of precursor proteins. 3Dpol was first observed at 1 h in polyacrylamide gels, with significant amounts being detected at 6 h and later. Initial attempts to assay for polymerase activity directly in the translation reaction were not successful. Polymerase activity, however, was easily detected by adding a small amount (3 microliters) of translation products to a standard polymerase assay containing poliovirion RNA. Full-length minus-strand RNA was synthesized in the presence of an oligo(U) primer. In the absence of oligo(U), product RNA about twice the size of virion RNA was synthesized in these reactions. RNA stability studies and plaque assays indicated that a significant fraction of the input virion RNA in the translation reactions was very stable and remained intact for 20 h or more. Plaque assays indicated that infectious virus was synthesized in the in vitro translation reactions. Under optimal conditions, the titer of infectious virus produced in the in vitro translation reactions was greater than 100,000 PFU/ml. Virus was first detected at 6 h and increased to maximum levels by 12 h. Overall, the kinetics of poliovirus replication (protein synthesis, polymerase activity, and virus production) observed in the HeLa S10-initiation factor in vitro translation reactions were similar to those observed in infected cells.
脊髓灰质炎病毒RNA聚合酶和感染性病毒颗粒是通过在体外HeLa S10提取物中翻译病毒粒子RNA合成的。体外翻译反应针对感染细胞中发现的病毒蛋白合成进行了优化,特别是病毒聚合酶3Dpol的合成。在反应的前6小时内,合成的标记蛋白量呈线性增加。由于前体蛋白的蛋白水解加工需要额外时间,翻译产物中3Dpol的出现有所延迟。在聚丙烯酰胺凝胶中,3Dpol在1小时时首次被观察到,6小时及之后能检测到大量的3Dpol。最初直接在翻译反应中检测聚合酶活性的尝试未成功。然而,通过向含有脊髓灰质炎病毒粒子RNA的标准聚合酶测定中加入少量(3微升)翻译产物,很容易检测到聚合酶活性。在寡聚(U)引物存在下合成了全长负链RNA。在没有寡聚(U)的情况下,这些反应中合成了约为病毒粒子RNA两倍大小的产物RNA。RNA稳定性研究和平板试验表明,翻译反应中输入的病毒粒子RNA有很大一部分非常稳定,在20小时或更长时间内保持完整。平板试验表明,体外翻译反应中合成了感染性病毒。在最佳条件下,体外翻译反应中产生的感染性病毒滴度大于100,000 PFU/ml。病毒在6小时时首次被检测到,并在12小时时增加到最高水平。总体而言,在HeLa S10起始因子体外翻译反应中观察到的脊髓灰质炎病毒复制动力学(蛋白质合成、聚合酶活性和病毒产生)与在感染细胞中观察到的相似。